Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice (Q37871253)
Jump to navigation
Jump to search
scientific article published on 02 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice |
scientific article published on 02 May 2011 |
Statements
1 reference
Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice (English)
1 reference
Francesco Trotta
1 reference
Hubert G M Leufkens
1 reference
Jan H M Schellens
1 reference
Richard Laing
1 reference
Giovanni Tafuri
1 reference
1 reference
Identifiers
1 reference